A followup to our NASH Market Research from 2018.
Understand the current Nonalcoholic steatohepatitis (NASH) treatment landscape and areas of unmet need
Explore what physicians know about the current state of affairs in the NASH market and pipeline and what physicians anticipate for the future of NASH treatment
Method: 10-minute MicroSurvey via InCrowd
Crowds: US Gastroenterologists, US Hepatologists
Sample Size: n=54
Fielding Period: March 6-7, 2019
One key finding:
- Physicians treat over 30 NASH patients in a typical month and are generally aware of treatments in development for NASH.
- They are diagnosing these patients using mostly blood tests and ultrasounds and sometimes use transient elastography, liver biopsy, and CT scan
Download the full report now!